Advisory Research Inc. purchased a new stake in shares of The Beauty Health Company (NASDAQ:SKIN) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 31,850 shares of the company’s stock, valued at approximately $827,000.

Several other institutional investors have also recently made changes to their positions in SKIN. PNC Financial Services Group Inc. increased its stake in shares of Beauty Health by 47.5% during the third quarter. PNC Financial Services Group Inc. now owns 1,962 shares of the company’s stock valued at $50,000 after buying an additional 632 shares during the period. Advisory Services Network LLC purchased a new position in shares of Beauty Health during the second quarter valued at $69,000. Emfo LLC purchased a new position in shares of Beauty Health during the third quarter valued at $78,000. Legal & General Group Plc purchased a new position in shares of Beauty Health during the second quarter valued at $96,000. Finally, Pinz Capital Management LP purchased a new position in shares of Beauty Health during the second quarter valued at $106,000. Hedge funds and other institutional investors own 62.08% of the company’s stock.

A number of equities research analysts recently weighed in on SKIN shares. Stifel Nicolaus started coverage on Beauty Health in a research report on Thursday, October 7th. They set a “buy” rating and a $33.00 price objective on the stock. Zacks Investment Research raised Beauty Health from a “hold” rating to a “buy” rating and set a $21.00 price objective on the stock in a research report on Thursday, January 13th. William Blair started coverage on Beauty Health in a research report on Friday, January 7th. They set an “outperform” rating on the stock. Raymond James started coverage on Beauty Health in a research report on Thursday, December 23rd. They set a “market perform” rating on the stock. Finally, Cowen started coverage on Beauty Health in a research report on Monday, October 4th. They set an “outperform” rating and a $32.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $28.22.

Shares of NASDAQ SKIN opened at $12.67 on Thursday. The business has a 50-day simple moving average of $21.91 and a two-hundred day simple moving average of $23.33. The Beauty Health Company has a fifty-two week low of $9.71 and a fifty-two week high of $30.17.

Beauty Health (NASDAQ:SKIN) last issued its quarterly earnings results on Monday, November 8th. The company reported ($1.63) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($1.60). The business had revenue of $68.15 million during the quarter, compared to analyst estimates of $59.57 million. On average, equities analysts anticipate that The Beauty Health Company will post -0.06 earnings per share for the current year.

About Beauty Health

Edge Systems, LLC designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal microdermabrasion systems; and light emitting diode systems.

Further Reading: What is an Initial Public Offering (IPO)?

Want to see what other hedge funds are holding SKIN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Beauty Health Company (NASDAQ:SKIN).